or Try an Advanced Search...

    Ophthalmology Stocks List

    Symbol Grade Name % Change
    MRK D Merck & Company, Inc. 2.48
    NVS F Novartis AG 0.74
    ALC F Alcon Inc. 0.08
    BCYC F Bicycle Therapeutics plc -0.49
    RXST F RxSight, Inc. 0.54
    SGRY F Surgery Partners, Inc. 3.73
    OPT F Opthea Limited -4.57
    CLSD F Clearside Biomedical, Inc. -2.86
    SGHT F Sight Sciences, Inc 0.80
    OCGN F Ocugen, Inc. -1.92
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Facilities Medical Devices Medical Instruments & Supplies Shell Companies
    Related Stock Lists: Eye Medicine Vision Blindness Eye Diseases Eyewear Retina Animal Health Antibiotics Biopharmaceutical Biotechnology Cataracts Contact Lenses Diabetes Diabetic Retinopathy Dry Eye Disease Eye Care Eye Care Professional Glaucoma Infectious Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Ophthalmology stocks.

    Symbol Grade Name Weight
    JFWD B Jacob Funds Inc. Jacob Forward ETF 7.97
    PSCH C PowerShares S&P SmallCap Health Care Portfolio 5.03
    AWEG B Alger Weatherbie Enduring Growth ETF 4.99
    PTH D Invesco DWA Healthcare Momentum ETF 3.79
    FFTY A Innovator IBD 50 Fund ETF 2.95
    View all Ophthalmology ETFs...
    Compare ETFs
    Compare AWEG to FFTY Compare AWEG to PTH Compare JFWD to PTH

        Ophthalmology Stocks Recent News

        Date Stock Title
        Nov 21 MRK Merck & Co., Inc. (MRK) Jefferies London Healthcare Conference
        Nov 21 NVS Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
        Nov 21 NVS Novartis buys gene therapy developer Kate for up to $1.1B
        Nov 21 NVS Novartis raises mid-term sales guidance
        Nov 21 NVS Novartis Lifts Midterm Sales Guidance Amid U.S. Expansion
        Nov 21 NVS Novartis wagers more than $1B on gene therapies for the nervous system
        Nov 21 MRK Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities
        Nov 21 MRK Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals
        Nov 21 NVS Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
        Nov 20 MRK Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care
        Nov 20 MRK Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
        Nov 20 RXST RxSight (RXST) Upgraded to Buy: Here's What You Should Know
        Nov 20 OCGN Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease
        Nov 19 SGHT Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference
        Nov 19 MRK Merck readies new Keytruda version ahead of major regulatory headwinds
        Nov 19 MRK Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
        Nov 19 MRK Merck raises dividend to $0.81/share
        Nov 19 MRK Merck Announces First-Quarter 2025 Dividend
        Nov 19 MRK Merck: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
        Nov 19 OCGN Ocugen reports positive data for OCU400, OCU410
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Facilities Medical Devices Medical Instruments & Supplies Shell Companies
        Related Stock Lists: Glaucoma Medicine Cataracts Diabetic Retinopathy Eye Macular Degeneration Retinopathy Urology Vision Biopharmaceutical Blindness Cornea Eye Surgery Inflammation Laser Laser System Ophthalmic Organ Systems Retina Retinal Diseases
        Ophthalmology

        Ophthalmology (, or ) is a branch of medicine and surgery (both methods are used) that deals with the diagnosis and treatment of eye disorders. An ophthalmologist is a specialist in Ophthalmology. Their credentials include a doctorate degree in medicine, followed by an additional four years of Ophthalmology residency training. They may or may not receive residency training in internal medicine, pediatrics, or general surgery before the ophthalmology residency. Additional training may be sought through a fellowship in a particular specialty of eye pathology. Ophthalmologists are allowed to use medications to treat eye diseases, implement laser therapy, and perform surgery when needed. Ophthalmologists may participate in academic research on the diagnosis and treatment for eye disorders.

        More about Ophthalmology
        Browse All Tags